Developing a Prognostic Information System for Personalized Care in Real Time
暂无分享,去创建一个
Tracy A. Lieu | Lisa J. Herrinton | Dimitri E. Buzkov | Liyan Liu | Deborah Lyons | Romain Neugebauer | Tami Needham | Daniel Ng | Stephanie Prausnitz | Kam Stewart | Stephen K. Van Den Eeden | David M. Baer | T. Lieu | S. K. Van Den Eeden | L. Herrinton | R. Neugebauer | Liyan Liu | D. Baer | Stephanie Prausnitz | Daniel Ng | Deborah Lyons | Tami Needham | Kam Stewart
[1] Su-Xu Yuan,et al. Prognostic factors in patients with pancreatic cancer. , 2012, Experimental and therapeutic medicine.
[2] James M Robins,et al. Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available. , 2016, American journal of epidemiology.
[3] G. Hortobagyi,et al. Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] S. Martino,et al. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. , 2000, The New England journal of medicine.
[5] Andrew Nguyen,et al. ARTIFICIAL INTELLIGENCE FOR THE REAL WORLD , 2023, International Research Journal of Modernization in Engineering Technology and Science.
[6] H. Welch,et al. Presumed benefit: lessons from the American experience with marrow transplantation for breast cancer , 2002, British medical journal.
[7] Development and Validation of a Nomogram for Predicting Survival in Patients with Advanced Pancreatic Ductal Adenocarcinoma , 2017, Scientific Reports.
[8] J. Rassen,et al. Confounding Control in Healthcare Database Research: Challenges and Potential Approaches , 2010, Medical care.
[9] Jeffrey E. Lee,et al. Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancer. , 2012, Archives of surgery.
[10] M. Lippman,et al. High-dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer. , 2000, The New England journal of medicine.
[11] Amela,et al. CONVENTIONAL-DOSE CHEMOTHERAPY COMPARED WITH HIGH-DOSE CHEMOTHERAPY PLUS AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR METASTATIC BREAST CANCER , 2000 .
[12] U. Chettipally,et al. Optimizing Clinical Decision Support in the Electronic Health Record , 2016, Applied Clinical Informatics.
[13] R. Gale,et al. Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants. , 1988, Annals of internal medicine.
[14] Eileen M. Walsh,et al. A Quantitative, Risk-Based Approach to the Management of Neonatal Early-Onset Sepsis , 2017, JAMA pediatrics.
[15] J. Frankovich,et al. Evidence-based medicine in the EMR era. , 2011, The New England journal of medicine.
[16] Patricia Kipnis,et al. Risk-adjusting Hospital Mortality Using a Comprehensive Electronic Record in an Integrated Health Care Delivery System , 2013, Medical care.
[17] Ewout W. Steyerberg,et al. Big Data and Predictive Analytics: Recalibrating Expectations , 2018, JAMA.